Validation of the NEOS score in Chinese patients with anti-NMDAR encephalitis

Conclusions The NEOS score is considered a reliable predictor of the risk of 1-year poor functional status in Chinese patients with anti-NMDAR encephalitis. This score could help to estimate the velocity of clinical improvement in advance. Clinicaltrial.gov identifier NCT02443350. Classification of evidence This study provides Class III evidence that in patients with anti-NMDAR encephalitis, the NEOS score predicts 1-year functional status.

http://nn.neurology.org/cgi/content/short/7/5/e860?rss=1

Source: Neurology Neuroimmunology and Neuroinflammation - August 4, 2020 Category: Neurology Authors: Peng, Y., Dai, F., Liu, L., Chen, W., Yan, H., Liu, A., Zhang, X., Wang, X., He, J., Li, Y., Li, C., Chen, L., Zhao, Y., Li, L., Ma, Q., Wang, J. Tags: Autoimmune diseases, Encephalitis, Prognosis, Clinical trials Observational study (Cohort, Case control), Class III Article Source Type: research